|
1
|
Farquhar C, Rishworth JR, Brown J, Nelen
WL and Marjoribanks J: Assisted reproductive technology: An
overview of Cochrane Reviews. Cochrane Database Syst Rev.
7:CD0105372015.PubMed/NCBI
|
|
2
|
Broekmans FJ, Kwee J, Hendriks DJ, Mol BW
and Lambalk CB: A systematic review of tests predicting ovarian
reserve and IVF outcome. Hum Reprod Update. 12:685–718. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Loendersloot L, Repping S, Bossuyt PM,
van der Veen F and van Wely M: Prediction models in in vitro
fertilization; where are we? A mini review J Adv Res. 5:295–301.
2014. View Article : Google Scholar
|
|
4
|
Sunkara SK, Coomarasamy A, Arlt W and
Bhattacharya S: Should androgen supplementation be used for poor
ovarian response in IVF? Hum Reprod. 27:637–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fritz MA and Speroff L: Clinical
gynecologic endocrinology and infertility. 8th edition. Wolters
Kluwer Health/Lippincott Williams & Wilkins; Philadelphia:
2011
|
|
6
|
Soto N, Iñiguez G, López P, Larenas G,
Mujica V, Rey RA and Codner E: Anti-Mullerian hormone and inhibin B
levels as markers of premature ovarian aging and transition to
menopause in type 1 diabetes mellitus. Hum Reprod. 24:2838–2844.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Benaglia L, Somigliana E, w Vighi V, Ragni
G, Vercellini P and Fedele L: Rate of severe ovarian damage
following surgery for endometriomas. Hum Reprod. 25:678–682. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Raffi F, Metwally M and Amer S: The impact
of excision of ovarian endometrioma on ovarian reserve: A
systematic review and meta-analysis. J Clin Endocrinol Metab.
97:3146–3154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang HH, Chen MJ, Lu MY, Chern JP, Lu CY,
Yang YL, Jou ST, Lin DT, Yang YS and Lin KH: Iron overload is
associated with low anti-müllerian hormone in women with
transfusion-dependent β-thalassaemia. BJOG. 118:825–831. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hehenkamp WJ, Volkers NA, Broekmans FJ, de
Jong FH, Themmen AP, Birnie E, Reekers JA and Ankum WM: Loss of
ovarian reserve after uterine artery embolization: A randomized
comparison with hysterectomy. Hum Reprod. 22:1996–2005. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tropeano G, Di Stasi C, Amoroso S, Gualano
MR, Bonomo L and Scambia G: Long-term effects of uterine fibroid
embolization on ovarian reserve: A prospective cohort study. Fertil
Steril. 94:2296–2300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Vos M, Devroey P and Fauser BC: Primary
ovarian insufficiency. Lancet. 376:911–921. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gurtcheff SE and Klein NA: Diminished
ovarian reserve and infertility. Clin Obstet Gynecol. 54:666–674.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lawson R, El-Toukhy T, Kassab A, Taylor A,
Braude P, Parsons J and Seed P: Poor response to ovulation
induction is a stronger predictor of early menopause than elevated
basal FSH: A life table analysis. Hum Reprod. 18:527–533. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leonardi MR, Hofmann GE, Illions EH, Neal
GS and Navot D: A prospective evaluation of clomiphene citrate
challenge test screening of the general infertility population.
Obstet Gynecol. 82:539–544. 1993.PubMed/NCBI
|
|
16
|
May-Panloup P, Ferré-L'Hôtellier V,
Morinière C, Marcaillou C, Lemerle S, Malinge MC, Coutolleau A,
Lucas N, Reynier P, Descamps P and Guardiola P: Molecular
characterization of corona radiata cells from patients with
diminished ovarian reserve using microarray and microfluidic-based
gene expression profiling. Hum Reprod. 27:829–843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lledo B, Ortiz JA, Llacer J and Bernabeu
R: Pharmacogenetics of ovarian response. Pharmacogenomics.
15:885–893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Juengel JL and McNatty KP: The role of
proteins of the transforming growth factor-beta superfamily in the
intraovarian regulation of follicular development. Hum Reprod
Update. 11:143–160. 2005.PubMed/NCBI
|
|
19
|
Mehlmann LM: Stops and starts in mammalian
oocytes: Recent advances in understanding the regulation of meiotic
arrest and oocyte maturation. Reproduction. 130:791–799. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pangas SA and Rajkovic A: Transcriptional
regulation of early oogenesis: In search of masters. Hum Reprod
Update. 12:65–76. 2006. View Article : Google Scholar
|
|
21
|
Greene AD, Patounakis G and Segars JH:
Genetic associations with diminished ovarian reserve: A systematic
review of the literature. J Assist Reprod Genet. 31:935–946. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vitt UA, Hayashi M, Klein C and Hsueh AJ:
Growth differentiation factor-9 stimulates proliferation but
suppresses the follicle-stimulating hormone-induced differentiation
of cultured granulosa cells from small antral and preovulatory rat
follicles. Biol Reprod. 62:370–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin
JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL, et al:
Synergistic roles of bone morphogenetic protein 15 and growth
differentiation factor 9 in ovarian function. Mol Endocrinol.
15:854–866. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Orisaka M, Orisaka S, Jiang JY, Craig J,
Wang Y, Kotsuji F and Tsang BK: Growth differentiation factor 9 is
antiapoptotic during follicular development from preantral to early
antral stage. Mol Endocrinol. 20:2456–2468. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yeo CX, Gilchrist RB, Thompson JG and Lane
M: Exogenous growth differentiation factor 9 in oocyte maturation
media enhances subsequent embryo development and fetal viability in
mice. Hum Reprod. 23:67–73. 2008. View Article : Google Scholar
|
|
26
|
Laissue P, Christin-Maitre S, Touraine P,
Kuttenn F, Ritvos O, Aittomaki K, Bourcigaux N, Jacquesson L,
Bouchard P, Frydman R, et al: Mutations and sequence variants in
GDF-9 and BMP15 in patients with premature ovarian failure. Eur J
Endocrinol. 154:739–744. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chand AL, Ponnampalam AP, Harris SE,
Winship IM and Shelling AN: Mutational analysis of BMP15 and GDF-9
as candidate genes for premature ovarian failure. Fertil Steril.
86:1009–1012. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kovanci E, Rohozinski J, Simpson JL, Heard
MJ, Bishop CE and Carson SA: Growth differentiating factor-9
mutations may be associated with premature ovarian failure. Fertil
Steril. 87:143–146. 2007. View Article : Google Scholar
|
|
29
|
Wang TT, Wu YT, Dong MY, Sheng JZ, Leung
PC and Huang HF: G546A polymorphism of growth differentiation
factor-9 contributes to the poor outcome of ovarian stimulation in
women with diminished ovarian reserve. Fertil Steril. 94:2490–2492.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alpha Scientists in Reproductive Medicine
and ESHRE Special Interest Group of Embryology: The Istanbul
consensus workshop on embryo assessment: Proceedings of an expert
meeting. Hum Reprod. 26:1270–1283. 2011. View Article : Google Scholar
|
|
31
|
Aljanabi SM and Martinez I: Universal and
rapid salt-extraction of high quality genomic DNA for PCR-based
techniques. Nucleic Acids Res. 25:4692–4693. 1997. View Article : Google Scholar
|
|
32
|
Dong J, Albertini DF, Nishimori K, Kumar
TR, Lu N and Matzuk MM: Growth differentiation factor-9 is required
during early ovarian folliculogenesis. Nature. 383:531–535. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin
JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL, et al:
Synergistic roles of bone morphogenetic protein 15 and growth
differentiation factor 9 in ovarian function. Molecular
Endocrinology. 15:854–866. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Su YQ, Wu X, O'Brien MJ, Pendola FL,
Denegre JN, Matzuk MM and Eppig JJ: Synergistic roles of BMP15 and
GDF-9 in the development and function of the oocyte-cumulus cell
complex in mice: Genetic evidence for an oocyte-granulosa cell
regulatory loop. Dev Biol. 276:64–73. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liao WX, Moore RK, Otsuka F and Shimasaki
S: Effect of intracellular interactions on the processing and
secretion of bone morphogenetic protein-15 (BMP-15) and growth and
differentiation factor-9. Implication of the aberrant ovarian
phenotype of BMP-15 mutant sheep. J Biol Chem. 278:3713–3719. 2003.
View Article : Google Scholar
|
|
36
|
Ma L, Chen Y, Mei S, Liu C, Ma X, Li Y,
Jiang Y, Ha L and Xu X: Single nucleotide polymorphisms in
premature ovarian failure-associated genes in a Chinese Hui
population. Mol Med Rep. 12:2529–2538. 2015.PubMed/NCBI
|
|
37
|
Dixit H, Rao LK, Padmalatha V, Kanakavalli
M, Deenadayal M, Gupta N, Chakravarty B and Singh L: Mutational
screening of the coding region of growth differentiation factor 9
gene in Indian women with ovarian failure. Menopause. 12:749–754.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takebayashi K, Takakura K, Wang H, Kimura
F, Kasahara K and Noda Y: Mutation analysis of the growth
differentiation factor-9 and-9B genes in patients with premature
ovarian failure and polycystic ovary syndrome. Fertil Steril.
74:976–979. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Norling A, Hirschberg AL,
Rodriguez-Wallberg KA, Iwarsson E, Wedell A and Barbaro M:
Identification of a duplication within the GDF-9 gene and novel
candidate genes for primary ovarian insufficiency (POI) by a
customized high-resolution array comparative genomic hybridization
platform. Hum Reprod. 29:1818–1827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang B, Zhou S, Wang J, Liu J, Ni F, Yan
J, Mu Y, Cao Y and Ma X: Identification of novel missense mutations
of GDF-9 in Chinese women with polycystic ovary syndrome. Reprod
Biomed Online. 21:344–348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sproul K, Jones MR, Mathur R, Azziz R and
Goodarzi MO: Association study of four key folliculogenesis genes
in polycystic ovary syndrome. BJOG. 117:756–760. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Peng J, Li Q, Wigglesworth K, Rangarajan
A, Kattamuri C, Peterson RT, Eppig JJ, Thompson TB and Matzuk MM:
Growth differentiation factor 9: Bone morphogenetic protein 15
heterodimers are potent regulators of ovarian functions. Proc Natl
Acad Sci USA. 110:E776–E785. 2013. View Article : Google Scholar
|
